2017 Q1 Form 10-Q Financial Statement
#000114420417028850 Filed on May 22, 2017
Income Statement
Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | $0.00 | $0.00 | |
YoY Change | |||
Gross Profit | $0.00 | $0.00 | |
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $81.74K | ||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $13.18K | ||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $153.00 | $0.00 | |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $226.0K | $1.400K | |
YoY Change | 16045.64% | ||
Operating Profit | -$226.0K | -$1.400K | |
YoY Change | 16045.64% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$1.585K | ||
YoY Change | |||
Pretax Income | -$227.6K | -$1.400K | |
YoY Change | 16158.86% | ||
Income Tax | $200.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$227.8K | -$1.400K | |
YoY Change | 16173.14% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | |||
COMMON SHARES | |||
Basic Shares Outstanding | 26.51M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $50.17K | $9.087K | $0.00 |
Short-Term Investments | |||
Other Short-Term Assets | $3.648K | ||
YoY Change | |||
Inventory | $12.93K | ||
Prepaid Expenses | $56.78K | $12.34K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $2.372M | $164.1K | |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $462.00 | ||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $462.00 | ||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $2.372M | $164.1K | |
Total Long-Term Assets | $462.00 | ||
Total Assets | $164.5K | ||
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $9.984K | $13.49K | |
YoY Change | 259.84% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $9.984K | $431.7K | |
YoY Change | 11411.63% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $224.0K | |
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $224.0K | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $9.984K | $431.7K | |
Total Long-Term Liabilities | $0.00 | $224.0K | |
Total Liabilities | $9.984K | $237.5K | |
YoY Change | 6233.17% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$191.6K | -$1.934M | |
YoY Change | 47507.34% | ||
Common Stock | $2.556M | $1.664M | |
YoY Change | 71876.43% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.362M | -$267.2K | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $2.372M | $164.5K | |
YoY Change |
Cashflow Statement
Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$227.8K | -$1.400K | |
YoY Change | 16173.14% | ||
Depreciation, Depletion And Amortization | $153.00 | $0.00 | |
YoY Change | |||
Cash From Operating Activities | -$158.9K | -$40.00K | |
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $200.0K | $0.00 | |
YoY Change | |||
Cash From Investing Activities | $200.0K | $0.00 | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $2.260M | $0.00 | |
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | ||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -$158.9K | -40.00K | |
Cash From Investing Activities | $200.0K | 0.000 | |
Cash From Financing Activities | 0.000 | ||
Net Change In Cash | $41.09K | -40.00K | |
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$158.9K | -$40.00K | |
Capital Expenditures | $0.00 | ||
Free Cash Flow | -$40.00K | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
69413 | USD |
CY2017Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2553165 | USD |
CY2017Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2362224 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
30721 | USD |
CY2017Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2372208 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
268215 | USD |
CY2017Q1 | us-gaap |
Assets Current
AssetsCurrent
|
2372208 | USD |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
268215 | USD |
CY2017Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9984 | USD |
CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13494 | USD |
CY2017Q1 | us-gaap |
Common Stock Discount On Shares
CommonStockDiscountOnShares
|
2060 | USD |
CY2016Q4 | us-gaap |
Common Stock Discount On Shares
CommonStockDiscountOnShares
|
2060 | USD |
CY2017Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-191575 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39078 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2068924 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
213181 | USD |
CY2017Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
56783 | USD |
CY2016Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
29000 | USD |
CY2017Q1 | us-gaap |
Due From Related Parties Current
DueFromRelatedPartiesCurrent
|
35634 | USD |
CY2016Q4 | us-gaap |
Due From Related Parties Current
DueFromRelatedPartiesCurrent
|
26034 | USD |
CY2017Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
224000 | USD |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
237494 | USD |
CY2017Q1 | us-gaap |
Liabilities
Liabilities
|
9984 | USD |
CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1400 | USD |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
154660 | USD |
CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1400 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-152497 | USD |
CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
20000000 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
25782289 | shares |
CY2017Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2017Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9984 | USD |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
13494 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2017Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
2694 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2446 | USD |
CY2017Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2163 | USD |
CY2016Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD |
CY2017Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
9600 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
0 | USD |
CY2017Q1 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
-51760 | USD |
CY2016Q1 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
1400 | USD |
CY2017Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2016Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2017Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2016Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2017Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
CY2016Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-152497 | USD |
CY2016Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1400 | USD |
CY2016Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2017Q1 | cik0001662684 |
Working Capital Deficit
WorkingCapitalDeficit
|
2362224 | USD |
CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2016Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2017Q1 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-3510 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-204257 | USD |
CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2260000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
2260000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1855743 | USD |
CY2016Q1 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
1150 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
250 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
0 | USD |
CY2016Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
0 | USD |
CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
0 | USD |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2016Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
27783 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
0 | USD |
CY2017Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
9984 | USD |
CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
13494 | USD |
CY2017Q1 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
200000 | USD |
CY2016Q4 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
0 | USD |
CY2017Q1 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
2139 | USD |
CY2016Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
0 | USD |
CY2017Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
8728 | USD |
CY2016Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
0 | USD |
CY2017Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2017Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2016Q1 | us-gaap |
Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
|
0 | USD |
CY2017Q1 | us-gaap |
Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
|
200000 | USD |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2017Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
26944000 | shares |
CY2017Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26944000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24460000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24460000 | shares |
CY2017Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
2139 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
-8728 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
0 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-200000 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
0 | USD |
CY2017Q1 | us-gaap |
Stock Issued1
StockIssued1
|
224000 | USD |
CY2016Q1 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2017Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <u><font style="mso-bidi-font-size: 10.0pt">USE OF ESTIMATES</font></u><font style="mso-bidi-font-size: 10.0pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="mso-bidi-font-size: 10.0pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="mso-bidi-font-size: 10.0pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the periods. The Company’s significant estimates and assumptions include the fair value of the Company’s stock and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> |